Tuesday, October 17, 2017

Imprimis Pharmaceuticals, Inc. (IMMY) Reaches 52-Week Low

Highlight Press-1 hour ago
The Company operates through the business of developing drug therapies ... on developing and dispensing a portfolio of non-proprietary compounded drugs for ...
Post a Comment